Pure Global

Assessment of Nanocrystalline Hydroxyapatite Versus Autogenous Bone Grafts : A Comparative Clinical Study in Alveolar Cleft Grafting - Trial NCT04693559

Access comprehensive clinical trial information for NCT04693559 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Alveolar Cleft. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04693559
Not yet recruiting
procedure
Trial Details
ClinicalTrials.gov โ€ข NCT04693559
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Assessment of Nanocrystalline Hydroxyapatite Versus Autogenous Bone Grafts : A Comparative Clinical Study in Alveolar Cleft Grafting

Study Focus

Alveolar Cleft

secondary alveolar bone graft

Interventional

procedure

Sponsor & Location

Assiut University

Timeline & Enrollment

N/A

Jan 01, 2021

Mar 01, 2023

20 participants

Primary Outcome

Measuring of bone volume 6 months post-operative

Summary

This work aims to evaluate Nanocrystalline Hydroxyapatite versus Autogenous bone grafts in
 alveolar cleft grafting

ICD-10 Classifications

Cleft palate
Cleft palate, unspecified
Cleft soft palate
Other branchial cleft malformations
Cleft uvula

Data Source

ClinicalTrials.gov

NCT04693559

Non-Device Trial